mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |